These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7849812)

  • 1. Chronic granulomatous disease: newly defined molecular abnormalities explain disease variability and normal phagocyte physiology.
    Forehand JR; Johnston RB
    Curr Opin Pediatr; 1994 Dec; 6(6):668-75. PubMed ID: 7849812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI
    Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic granulomatous disease: diagnosis and classification at the molecular level.
    Hopkins PJ; Bemiller LS; Curnutte JT
    Clin Lab Med; 1992 Jun; 12(2):277-304. PubMed ID: 1611821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for chronic granulomatous disease.
    Kume A; Dinauer MC
    J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in gene therapy for chronic granulomatous disease.
    Malech HL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic granulomatous disease: towards gene therapy.
    Thrasher A; Segal A; Casimir C
    Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
    Stasia MJ; Bordigoni P; Martel C; Morel F
    Hum Genet; 2002 May; 110(5):444-50. PubMed ID: 12073015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
    Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
    Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.
    Roos D; de Boer M; Köker MY; Dekker J; Singh-Gupta V; Ahlin A; Palmblad J; Sanal O; Kurenko-Deptuch M; Jolles S; Wolach B
    Hum Mutat; 2006 Dec; 27(12):1218-29. PubMed ID: 16972229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.
    Wolach B; Gavrieli R; de Boer M; Gottesman G; Ben-Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Etzioni A; Roos D
    Clin Immunol; 2008 Oct; 129(1):103-14. PubMed ID: 18708296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel element in the management of chronic granulomatous disease (CGD)? - treatment of osteomyelitis with additional hyperbaric oxygen therapy (HBO).
    Beltz K; Christaras A; Kovacevic A; Schaper J; Strelow H; Niehues T
    Klin Padiatr; 2008; 220(6):380-3. PubMed ID: 18949675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.
    Tauber AI; Borregaard N; Simons E; Wright J
    Medicine (Baltimore); 1983 Sep; 62(5):286-309. PubMed ID: 6353131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of chronic granulomatous disease in Turkish families.
    Köker MY; Sanal O; De Boer M; Tezcan I; Metin A; Ersoy F; Roos D
    Eur J Clin Invest; 2007 Jul; 37(7):589-95. PubMed ID: 17576211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for a genetic defect in Polish patients with chronic granulomatous disease.
    Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
    Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
    Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease: a case report.
    Ma JS; Chen PY; Fu LS; Chi CS; Huang YF; Lin CY; Shieh CC
    J Microbiol Immunol Infect; 2000 Jun; 33(2):118-22. PubMed ID: 10917883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward effective gene therapy for chronic granulomatous disease.
    Malech HL; Choi U; Brenner S
    Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and biochemical background of chronic granulomatous disease.
    Jurkowska M; Bernatowska E; Bal J
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.